BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Galenea 

790 Memorial Drive, Suite 202

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-374-1010 Fax: 617-374-1320


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
Galenea Awarded $3 Million National Institutes of Health (NIH) Grant to Develop Translational EEG Biomarkers for Schizophrenia 9/6/2012 10:20:02 AM
Galenea and CHDI Foundation Announce Extension and Expansion of Huntington's Disease Collaboration 8/9/2012 10:32:45 AM
Timothy A. Ryan, PhD Joins Galenea's Scientific Advisory Board 7/16/2012 9:48:41 AM
Galenea and Eisai Company, Ltd. (ESALY.PK) Enter into Research Collaboration to Develop Synaptic Modulators for Neurodegenerative Diseases 7/10/2012 10:20:58 AM
Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program 4/26/2012 7:50:02 AM
Galenea Announces Publication Describing High Throughput Screening System for Modulators of Synaptic Function 10/11/2011 8:09:35 AM
Galenea Announces Publication Describing High Throughput Screening System for Modulators of Synaptic Function 10/6/2011 12:45:42 PM
Galenea Awarded Two SBIR Grants to Advance Innovative Approaches for the Discovery and Development of Effective Treatments for Schizophrenia 9/28/2011 10:44:04 AM
Galenea and CHDI Foundation Announce Collaboration to Identify Key Synaptic Dysfunction in Huntington's Disease 9/6/2011 11:58:02 AM
Galenea Awarded $4.5 Million Grant for Advancement of Innovative Synaptic Transmission Screen 10/15/2010 6:54:25 AM
123